Web-based Intervention for Long-term Breast Cancer Survivors
CUMACA-M
A Web-based Tailored Intervention to Improve the Quality of Life of Long-term Breast Cancer Survivors. A Randomized Controlled Trial
1 other identifier
interventional
182
1 country
1
Brief Summary
The number of breast cancer survivors is growing. More cured women are becoming long-term survivors of breast cancer (LS-BC) at least 5 years after diagnosis and after treatment has been completed. Some of these LS-BC return to daily life without any problems; however, in many cases, they experience and have to deal with physical sequelae (chronic fatigue, pain, etc.) psychological sequelae (anxiety, depression, fear of recurrence, etc.) and social sequelae (altered interpersonal relationships, difficulty in returning to work, etc.). For many LS-BC, these health problems are not being met by health professionals. Thus there is a need to promote greater continuity and coordination between specialized oncology care and primary health care in order to enhance specific follow-up of these women in the community. However, the role of the primary health care team in the provision of care in the long-term cancer survival is not clearly defined and few actions have been aimed at improving care activities, standardizing procedures and protocols, developing documentation and registries and updating the training of health care professionals. Therefore, this study aim to design, implement, and evaluate a web based tailored intervention, using artificial intelligence, to improve the quality of life of long-term breast cancer survivors, and self-efficacy for the management of late sequelae from primary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2022
CompletedFirst Posted
Study publicly available on registry
April 11, 2022
CompletedStudy Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedSeptember 30, 2025
September 1, 2025
1.8 years
March 28, 2022
September 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Quality of life Cancer Survivor (QOL-CS)
The QOL-CS, Spanish version (Ferrell B, Hassey-Dow K, Grant M. Quality of Life Patient/Cancer Survivor Version (QOL-CS) \[Internet\]. Measurement Instrument Database for the Social Science. 2012). Scale specific for cancer survivor. Likert-type scale with 10 options (1 extremely poor and 10 excellent) with 41 items that measure the four domains of quality of life: physical, psychological, social and spiritual well-being.
Changes from baseline, 3-months, 6 months, and 9 month
Self-Efficacy for Managing Chronic Disease
The Self-Efficacy for Managing Chronic Disease- 6-Item Scale (SEMCD-6) (Ritter PL, Lorig K. The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol. 2014; 67(11): 1265-73). The scale is structured in 6 items related to symptom control, role performance, emotional state and communication with health professionals
Changes from baseline, 3-months, 6 months, and 9 month
Sociodemographic data of LS-BC
Sociodemographic data of the LS-BC (age, sex, marital status, educational level, employment status) will be collected by means of an ad hoc questionnaire at the beginning of the intervention.
Baseline
Secondary Outcomes (1)
Client Satisfaction Questionnaire (CSQ-8)
4 weeks
Study Arms (2)
Intervention group
EXPERIMENTALThe CUMACA-M Program will focus on a web-based tailored intervention, using artificial intelligence, for Long-Term Survivors of Breast Cancer. It will be structured into modules related to the specific needs of LS-BS, including physical, psychological, and social needs
Control group
NO INTERVENTIONUsual care in the nursing consultation in primary care
Interventions
The CUMACA-M Program will focus on a web-based tailored intervention, using artificial intelligence, for Long-Term Survivors of Breast Cancer. It will be structured into modules related to the specific needs of LS-BS, including physical, psychological, and social needs
Eligibility Criteria
You may qualify if:
- having been diagnosed with breast cancer
- having completed active oncological treatments (chemotherapy and/or radiotherapy) in a period of time greater than five years,
- be free of disease at the time of data collection
- be a woman and over 18 years of age
- have knowledge of Internet use.
You may not qualify if:
- Women with a diagnosis of cancer other than breast cancer
- Recurrence of cancer or metastasis that causes a new treatment
- Being in active treatment for recurrence or new cancer
- Being a man
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cristina García-Vivarlead
- Instituto de Salud Carlos IIIcollaborator
Study Sites (1)
Public University of Navarre
Pamplona, 31008, Spain
Related Publications (1)
Pimentel-Parra GA, Soto-Ruiz N, Escalada-Hernandez P, San Martin-Rodriguez L, Garcia-Vivar C. EHealth intervention for quality of life in long-term breast cancer survivors: Randomized controlled trial. J Natl Cancer Inst. 2026 Jan 24:djag020. doi: 10.1093/jnci/djag020. Online ahead of print.
PMID: 41581214DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Cristina Garcia Vivar, PhD
Universidad Pública de Navarra
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 28, 2022
First Posted
April 11, 2022
Study Start
December 15, 2023
Primary Completion
September 30, 2025
Study Completion
November 1, 2025
Last Updated
September 30, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share